Gastroenterology Research and Practice / 2017 / Article / Tab 2 / Clinical Study
Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections Table 2 Comparison of laboratory findings before and after treatment.
Before treatment After treatment valueWhite blood cell count (103 /mm3 ) 5.849 ± 1.515 5.891 ± 1.424 0.753 Hemoglobin (g/dL) 14.040 ± 1.288 13.928 ± 1.2409 0.123 Platelet count (103 /mm3 ) 228.33 ± 42.698 222.11 ± 41.633 0.054 Total protein (g/dL) 7.224 ± 0.386 7.230 ± 0.326 0.868 Albumin (g/dL) 4.506 ± 0.299 4.578 ± 0.268 0.025 Total bilirubin (mg/dL) 0.773 ± 0.448 0.750 ± 0.552 0.308 Aspartate transaminase (IU/L) 22.33 ± 4.862 22.70 ± 6.053 0.580 Alanine transaminase (IU/L) 21.95 ± 8.968 22.78 ± 10.624 0.472 Alkaline phosphatase (IU/L) 61.105 ± 16.448 62.150 ± 16.613 0.503 γ -Glutamyl transpeptidase (IU/L)22.09 ± 15.693 22.70 ± 13.756 0.063 Blood urea nitrogen (mg/dL) 13.620 ± 3.475 13.694 ± 3.376 0.863 Creatinine (mg/dL) 0.781 ± 0.173 0.755 ± 0.163 0.008 Glucose (mg/dL) 101.31 ± 13.392 99.95 ± 12.849 0.139 Total cholesterol (mg/dL) 200.14 ± 34.964 195.49 ± 30.820 0.185 Triglyceride (mg/dL) 133.56 ± 80.728 128.68 ± 80.598 0.462
.